Recent ASCIA website updates that are relevant to anaphylaxis and allergy include:

ASCIA Oral Immunotherapy (OIT) for Food Allergy Frequently Asked Questions (FAQ) for patients and carers - updated to add statements about impact on daily life and factors that can increase the risk of allergic reactions (including anaphylaxis)

New ASCIA Anaphylaxis Refresher Training video – developed to provide training which is accessible and hands-free learning that takes around 16 minutes to watch. Feedback is welcome by mid October 2024 as minor updates will be made at the end of next month.

New ASCIA Management Summary for Allergic Conditions - developed for health professionals to complete, to support continuity of care including transition from paediatric to adult medical care.

ASCIA Anaphylaxis Checklist for Young Adults - updated to make it easier to read and to include a link to Allergy 250K for young adults.

How to position a person having anaphylaxis - updated to include new ASCIA infographic showing how to position a person when adrenaline is given.

ASCIA Quicklinks - developed to improve access to ASCIA website information using QR codes.

ASCIA Anaphylaxis Facts for Parents and Carers – updated to include current information and make it easier to read.

New peanut allergy treatment program for babies in Australia - ten paediatric hospitals across five states have introduced a global first nation-wide peanut oral immunotherapy (OIT) program.

ASCIA application for MBS item for supervised oral food challenges - ASCIA has lodged an application for an MBS item number to improve access to supervised oral food challenges.

ASCIA anaphylaxis e-training reports - for the first time since ASCIA anaphylaxis e-training was introduced in 2010, reports have been developed based on mandatory feedback surveys. 

ASCIA Guidelines - Adrenaline (Epinephrine) Injector Prescription and ASCIA Guidelines - Acute Management of Anaphylaxis - updated to include EpiPen® Jr, EpiPen® and Anapen® 500 devices.

Request for initial adrenaline injector to be provided on PBS Authority prescription by clinical immunology/allergy specialist - updated to make the form easier to find on the ASCIA website.

ASCIA Adverse Reactions to Complementary and Alternative Medicine FAQ - updated to include information about allergic reactions to Andrographis paniculata.

ASCIA Guide for Milk Substitutes in Cow’s Milk Allergy - updated due to Alfaré^® extensively hydrolysed formula being discontinued in Australia and removed from the PBS from 1 August 2024.

This news item was issued on 7 August and updated on 17 September by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.